A Study to Determine Antibody Levels After Receiving COVID-19 Boosters of Any Kind

Discoveries - Different Immunization Boosters for Covid-19: Effect on Response in Antibodies

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05367908

Acronym

disCOVEries

Enrollment

1501

Registered

2022-05-10

Start date

2022-04-11

Completion date

2022-08-14

Last updated

2022-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV-2

Brief summary

This study will investigate antibody levels with respect to time since receiving a COVID-19 booster shot. The study will be decentralized, where participants can complete all study tasks at home. Self-reported participant information will be collected via surveys conducted at intake and monthly throughout the study. Participants will also perform monthly at-home capillary blood draws via YourBio devices that will be mailed to the designated laboratory for sample processing and antibody testing.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Lives in the continental United States. * Has been vaccinated against COVID-19 with a U.S.-authorized vaccine (that is, received the single shot J&J vaccine or both shots in the Pfizer or Moderna series). * Has received a COVID-19 booster between September 2021 and screening. * Is willing and able to submit vaccination card photo(s). * Is willing and able to self-collect capillary blood 3 times during the study period via an at-home whole-blood collection device (that is, the YourBio TAP II Device).

Exclusion criteria

* Has been diagnosed with significant cognitive impairment or dementia. * Has received more than one COVID-19 vaccine booster at screening. * Is currently participating in a COVID-19 vaccine clinical trial. * Is currently receiving chemotherapy or has received chemotherapy in the past 6 months. * Is currently taking steroids, such as prednisone, for any condition. * Has been diagnosed with or is taking medications for rheumatoid arthritis (RA), lupus or multiple sclerosis (MS). * Has received an organ transplant * Is currently undergoing dialysis of any kind (for example, hemodialysis or chronic ambulatory dialysis) for kidney disease.

Design outcomes

Primary

Measure	Time frame
Change in Antibody Levels Since Receiving a COVID-19 Booster Vaccine at 0, 1, and 2 Months Post Enrollment	Baseline (Month 0), Month 1, and Month 2

Countries

United States

Outcome results